Dementia/Alzheimer Disease
RSSArticles
-
Pharmacology Watch
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions. -
Cyclosporine A for Duchenne Muscular Dystrophy
Unfortunately, cyclosporine treatment had no effect on muscle power in children with Duchenne muscular dystrophy. -
Excessive Sleepiness and Narcolepsy: Clues from Genetics and Polysomnography
The accurate diagnosis of narcolepsy requires detailed history as well as physiological and genetic testing. -
Stroke Alert: A Review of Current Clinical Stroke Literature
-
Acute Unilateral Tongue Paralysis in Evolving GBS
-
Complications of Gamma Knife Surgery for Parkinson Disease
-
Does Cigarette Smoking Protect the Appearance of Parkinson’s Disease?
-
IVIG for Stiff-Person Syndrome
-
Clinical Criteria Identify Patients Able to Undergo LP Without CT Scan
-
Variant Huntington’s Disease